Add like
Add dislike
Add to saved papers

miR-217 represses TGF-β1-induced airway smooth muscle cell proliferation and migration through targeting ZEB1.

Aberrant proliferation and migration of airway smooth muscle cells (ASMCs) contribute to the pathogenesis of airway remodeling during asthma development. Here, the potential function of microRNA-217 (miR-217) on the cell proliferation and migration of TGF-β1-induced ASMCs and the involved mechanisms were investigated in this study. We found that miR-217 expression was apparently downregulated in a time and dose dependent characteristic in ASMCs exposed to transforming growth factor-β (TGF-β1) stimulation. Overexpression of miR-217 significantly inhibited TGF-β1-induced proliferation, migration, extracellular matrix (ECM) deposition, but promoted apoptosis in ASMCs, whereas, miR-217 inhibitor showed an opposed effect. Bioinformatics analyses revealed that the 3'-untranslated region (UTR) of ZEB1 was a potential target for miR-217, which was further confirmed by luciferase activity, qRT-PCR and western blot assay. In addition, rescue experiment also displayed that restoration of ZEB1 expression partially abrogated the inhibitory effect of miR-217 on TGF-β1-induced proliferation and migration in ASMCs. By chromatin immunoprecipitation (ChIP) assay, we further confirmed that the binding of ZEB1 to the fibronectin promoter in TGF-β1-treated ASMCs was reduced by miR-217 overexpression. Therefore, our findings suggested the potential protective role of miR-217 on the attenuation of cell proliferation and migration was through targeting ZEB1 in TGF-β1-stimulated ASMCs.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

Related Resources

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app